GNOM.US Global X Genomics & Biotechnology ETF

ETF Healthcare Equity Global X Funds USA Stocks
- USD
No recent price
Total assets
106M
Expense ratio
0.47%
Dividend yield
0.95%
1-year return
+47.51%
Holdings
50
Since
2019

Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.

What does GNOM.US invest in?

  • Mostly US stocks (96.0%)
  • Largest sector: Healthcare (96.2%)
  • Largest region: North America (97.5%)
  • Top 3 holdings: 22.8% of the fund

Asset allocation

  • US stocks 96.0%
  • Non-US stocks 4.7%

Top holdings

All holdings, sectors and regions

Global X Genomics & Biotechnology ETF performance

Sharpe ratio 0.79
This year
+45.21%
1 year
+47.51%
3 years
+20.70%
5 years
-5.51%

Volatility 26.3% over 1 year and 30.8% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

GNOM.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About Global X Genomics & Biotechnology ETF

The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.

Full fund profile